Skip to main content
1-featuredimage

Welcome to hubXchange's Oligonucleotide Therapeutics Xchange Europe 2025.

This event brings together senior-level scientists and executives from the pharmaceutical and biotech sectors to tackle key challenges in Innovation in Therapeutic Modalities, Translational & Clinical Strategy, Oligonucleotide CMC & Process Development.

Attendees can engage in roundtable discussions, pre-booked 1:1 meetingspresentations, and networking sessions with top industry experts, to foster collaboration and find innovative solutions to accelerate Oligonucleotides.

Take advantage of this unique highly interactive meeting format designed for maximum engagement, collaboration, and networking.

Munich | Tuesday 2nd December 2025 | 08:00am - 05:45pm

VIEW AGENDA    REGISTER FOR FREE   OUR PARTNERS    EVENT INFORMATION

Why choose hubXchange?

FULL AGENDA

Click the topic titles to find out more!

Loading
08:00
  1. Registration
    30 mins
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Drug Delivery
08:30
  1. Opening Address & Keynote Presentation:
    30 mins
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Drug Delivery
09:05
  1. Innovation in Therapeutic Modalities
    60 mins
    •  Innovation in Therapeutic Modalities
  2. Drug Delivery
    60 mins
    • Drug Delivery
    Enhancing efficacy and stability with novel oligonucleotide modifications and chemistries Beyond target mRNA KD: Diversifying oligo modalities and Mode of Actions Leveraging d AI/machine learning for ...
  3. Oligonucleotide CMC & Process Development
    60 mins
    • Oligonucleotide CMC & Process Development
    Defining acceptance criteria Over-designed oligonucleotide drugs - hurdles in upscaling and GMP analytics Expectations in scalability, quality, budget and time lines - finding an adequate CDMO Impact ...
10:10
  1. 1-2-1 Meetings/Networking Break
    30 mins
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Drug Delivery
10:40
  1. 1-2-1 Meetings/Networking Break
    30 mins
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Drug Delivery
11:10
  1. Morning Refreshments
    10 mins
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Drug Delivery
11:20
  1. Innovation in Therapeutic Modalities
    60 mins
    •  Innovation in Therapeutic Modalities
  2. Drug Delivery
    60 mins
    • Drug Delivery
  3. Translational & Clinical Strategy
    60 mins
    • Translational & Clinical Strategy

    ChemGenes

  4. Oligonucleotide CMC & Process Development
    60 mins
    • Oligonucleotide CMC & Process Development
12:20
  1. Networking Lunch
    60 mins
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Drug Delivery
13:25
  1. 30 mins
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Drug Delivery
14:00
  1. 1-2-1 Meetings/Networking Break
    30 mins
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Drug Delivery
14:30
  1. 1-2-1 Meetings/Networking Break
    30 mins
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Drug Delivery
15:00
  1. Afternoon Refreshments
    10 mins
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Drug Delivery
15:10
  1. Innovation in Therapeutic Modalities
    30 mins
    •  Innovation in Therapeutic Modalities

    Sylentis

  2. Drug Delivery
    30 mins
    • Drug Delivery
  3. Translational & Clinical Strategy
    30 mins
    • Translational & Clinical Strategy

    Chemgenes

  4. Oligonucleotide CMC & Process Development
    30 mins
    • Oligonucleotide CMC & Process Development
15:45
  1. Innovation in Therapeutic Modalities
    60 mins
    •  Innovation in Therapeutic Modalities
  2. Translational & Clinical Strategy
    60 mins
    • Translational & Clinical Strategy
     Optimizing delivery systems for respiratory RNA therapeutics  Stability and formulation challenges in respiratory administration  From bench to GMP: translating RNA therapeutics
  3. Oligonucleotide CMC & Process Development
    60 mins
    • Oligonucleotide CMC & Process Development
    Discussion Points:   1. Strategies for Enhancing Targeted Delivery with Next-Generation LNPs What advances in lipid composition, particle engineering, or surface modification are most promising for ce ...
16:45
  1. Evening Drinks Reception
    60 mins
    •  Innovation in Therapeutic Modalities
    • Translational & Clinical Strategy
    • Oligonucleotide CMC & Process Development
    • Drug Delivery

 

EVENT INFORMATION

3-featuredimage

DATES

Europe
Dec 2, 2025

Tuesday 2nd December 2025

 

DoubleTree by Hilton San Francisco Airport Hotel Photo

VENUE

Hilton Munich Airport Hotel

Terminalstraße Mitte 20
85356 München-Flughafen
Germany

MAP

4-featuredimage

EVENT PARTNERS

REGISTRATION FORM

5-featuredimage

Complimentary Registration is only available for Senior Scientists & above, in Pharma & Bio Tech, with an active drug pipeline.
 

For Service Providers, please click here.